RHEACELL announced today that it has entered into an exclusive partnership agreement with the AOP Health Group, who will ...

Initial programs will focus on developing innovative topical treatments and drug therapies for wound healing and itch relief, plus prophylactic therapies for people with Epidermolysis Bullosa.

This approval marks Abeona's entry into the commercial gene therapy market for dystrophic epidermolysis bullosa. LAS VEGAS, May 22, 2025 /PRNewswire/ -- Dystrophic epidermolysis bullosa (DEB ...

Epidermolysis Bullosa is rare, affecting just 1 in 50,000 people in the U.S., but it’s something the Campbells and their supporters are hoping to make sure no child ever has to go through.

Teenager Isla Grist has opened up on the constant struggle she faces living with a rare genetic skin blistering ­ condition.

Geneva, Switzerland Saturday, May 24, 2025, 15:30 Hrs [IST] ...

Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...

Brewer couple Hannah and Jacob Campbell say their daughter Elliana fought the life-threatening disease with strength and a smile on her face ...

This approval marks Abeona's entry into the commercial gene therapy market for dystrophic epidermolysis bullosa. The approval was granted based on results from the Phase III VIITAL study ...